JOURNAL OF THE CZECH PHARMACEUTICAL SOCIETY AND THE SLOVAK PHARMACEUTICAL SOCIETY

Čes. slov. farm. 2025, 74(3):172-178 | DOI: 10.36290/csf.2025.030

Resources and drug information on pharmacotherapy in breastfeeding

Kateřina Malá-Ládová1, Eliška Rožníčková1, Petra Rozsívalová1, 2
1 Katedra sociální a klinické farmacie, Farmaceutická fakulta UK v Hradci Králové
2 Oddělení klinické farmacie, Nemocniční lékárna, Fakultní nemocnice Hradec Králové

Breastfeeding is the optimal method of infant nutrition in early life, supporting physical health, reinforcing maternal-infant bonding, and offering economic and ecological benefits. The aim of this article is a narrative review of available professional information sources utilized by pharmacists, paediatricians, and other healthcare providers in breastfeeding pharmacotherapy decision-making. These include primary evidence (e.g., case reports, clinical lactation studies, adverse drug events reporting systems), secondary systematic reviews and meta-analyses, and tertiary sources comprising authoritative monographs (e.g., Hale's Medications & Mothers' Milk), clinical guidelines, or fact-based databases (e.g., LactMed, e-lactancia). Other information is received from regulatory documents (summary of product characteristics), websites for health care professionals, and drug information services (e.g., InfantRisk Center, Specialist Pharmacy Service). Access to such information sources enable individualized assessment of infant exposure while providing detailed data on drug transfer into breast milk, milk-to-plasma concentration ratios, and other pharmacokinetic properties, health condition of infant and mother as well as mother´s willingness to breastfeed. Critical appraisal of these sources with focus on current and evidence-based information are together with a multidisciplinary approach essential to ensure safe and effective treatment for breastfeeding women.

Keywords: drug compatibility with breastfeeding, drug information centre, lactation, professional information resources.

Accepted: September 15, 2025; Published: October 2, 2025  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Malá-Ládová K, Rožníčková E, Rozsívalová P. Resources and drug information on pharmacotherapy in breastfeeding. Čes. slov. farm. 2025;74(3):172-178. doi: 10.36290/csf.2025.030.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Purchase PDF - 40 CZK

    References

    1. Vachek J, Tesař V, Zakyianov O, et al. Farmakoterapie v těhotenství a při kojení. 2. vydání. Praha: Maxdorf Jesenius; 2016.
    2. Jirsová E. Principy farmakoterapie při kojení. Klin Farmakol Farm 2019;33(4):24-9. Go to original source...
    3. Briggs GG. Brigg´s Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk. 12. edition. Philadelphia, Pennsylvania: Wolters Kluwer Health; 2021.
    4. Hotham N, Hotham E. Drugs in breastfeeding. Aust Prescr. 2015;38(5):156-9. Go to original source...
    5. Anderson PO, Manoguerra AS, Valdés V. A Review of Adverse Reactions in Infants from Medications in Breastmilk. Clin Pediatr. 2016;55(3):236-44. Go to original source...
    6. Foong SC, Tan ML, Foong WC, et al. Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants. Cochrane Database Syst Rev. 2020;5(5):CD011505. Go to original source...
    7. Oladapo OT, Fawole B. Treatments for suppression of lactation. Cochrane Database Syst Rev. 2012;2012(9):CD005937. Go to original source...
    8. Jordan S, Bromley R, Damase-Michel C, et al. Breastfeeding, pregnancy, medicines, neurodevelopment, and population databases: the information desert. Int Breastfeed J. 2022 Aug 2;17(1):55. Go to original source...
    9. Questions to ask when giving advice on medicines and breastfeeding. [Internet]. UK: Specialist Pharmacy Service; c2025. [cit. 3. 6. 2025]. Available from: https://www.sps.nhs.uk/articles/questions-to-ask-when-giving-advice-on-medicines-and-breastfeeding/
    10. Rožníčková E. Analýza dotazů lékového informačního centra zaměřených na farmakoterapii u těhotných a kojících žen. Hradec Králové: Univerzita Karlova, Farmaceutická fakulta v Hradci Králové; 2023.
    11. Malá-Ládová K, Rožníčková E, Rozsívalová P. Zdroje dat a odborných informací o farmakoterapii v těhotenství. Čes. slov. Farm. 2025;74(2):108-13. Go to original source...
    12. Malone P, Kier KL, Stanovich JE, Malone MJ. Drug information: a guide for pharmacists. 5. edition. New York: Mc Graw Hill Education. 2014.
    13. Ainsworth SS. Neonatal Formulary: Drug Use in Pregnancy and the First Year of Life. 8. edition. Oxford: Oxford University Press; 2020. Go to original source...
    14. Schaefer C, Peters PWJ, Miller RK. Drugs During Pregnancy and Lactation: Treatment Options and Risk Assessment. 3. edition. London: Academic Press; 2015.
    15. Tížková K. Tabulky léčiv v těhotenství a při kojení. 1. vydání. Praha: Maxdorf; 2023.
    16. Adámková V. Antibiotika a infekce v těhotenství a laktaci. 1. vydání. Praha: Grada; 2022.
    17. Hale WT, Krutsch K. Hale's Medications & Mothers' Milk 2025-2026: A Manual of Lactational Pharmacology. 21. edition. Princeton: Springer Publishing; 2025.
    18. Micromedex® (electronic version). [Internet]. Michigan, USA: Merative, Ann Arbor; c2025. [cit. 3. 6. 2025]. Available from: https://www.micromedexsolutions.com/.
    19. BNF for Children (BNFC). 2024-2025 edition. London, UK: Pharmaceutical Press; 2024.
    20. Drugs and Lactation Database (LactMed®). [Internet]. Bethesda (MD): National Institute of Child Health and Human Development. National Library of Medicine; c2025. [cit. 3. 6. 2025]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK501922/ .
    21. e-lactancia. Is it compatible with breastfeeding? [Internet]. APILAM, Association for Promotion of and cultural and scientific Research into Breastfeeding; c2025 [cit. 7. 6. 2025]. Available from: http://www.e-lactancia.org.
    22. Health Professionals. [Internet]. Melbourne, Australia: The Royal Women's Hospital; c2025. [cit. 6. 6. 2025]. Available from: https://www.thewomens.org.au/health-professionals
    23. Breastfeeding and maternal medication: recommendations for drugs in the Eleventh WHO Model List of Essential Drugs. [Internet]. Geneva, Switzerland: World Health Organization. World Health Organization (2003). [cit. 16. 6. 2025]. Available from: https://iris.who.int/handle/10665/62435.
    24. FASS Patient. [Internet]. Stockholm, Sweden: Fass; c2025. [cit. 16. 6. 2025]. Available from: https://www.fass.se/LIF/startpage.
    25. Bundesverband der Pharmazeutischen Industrie. Rote Liste. Arzneimittelverzeichnis für Deutschland. Frankfurt: Aulendorf; 2004.
    26. U.S. Food and Drug Administration. Pregnancy and Lactation Labeling Resources [Internet]. Silver Spring, USA: FDA. c2025. [cit. 18. 6. 2025]. Available from: https://www.fda.gov/drugs/labeling-information-drug-products/pregnancy-and-lactation-labeling-resources
    27. Cybele: For the most important people in the world: the unborn and the newborn. [Internet]. Leuven, Belgium: Cybele; c2025. [cit. 3. 2. 2025]. Available from: https://www.cybele.be.
    28. Infpreg: Kunskapscentrum för infektioner under graviditet. [Internet]. Stockholm, Sweden: Infpreg; c2025. [cit. 9. 2. 2025]. Available from: https://www.medscinet.se/InfPreg/default.aspx.
    29. Janusmed. [Internet]. Stockholm, Sweden: Janusmed; c2025. [cit. 4. 2. 2025]. Available from: https://janusmed.se/.
    30. Maternity and Infant Care (MIC) database. [Internet]. London, UK: Midirs; c2025. [cit. 4. 2. 2025]. Available from: https://rcm.org.uk/midirs/midirs-maternity-and-infant-care/.
    31. Doporučené postupy. [Internet]. Praha, ČR: Česká lékárnická komora; c2025. [cit. 21. 6. 2025]. Available from: https://lekarnici.cz/kategorie/dokumenty/doporucene-postupy/
    32. The Breastfeeding Network. [Internet]. Paisley, UK: The Breastfeeding Network. Registered Charity No SC027007; c2025. [cit. 6. 6. 2025]. Available from: https://www.breastfeedingnetwork.org.uk.
    33. Byrne JJ, Spong CY. "Is It Safe?" - The Many Unanswered Questions about Medications and Breast-Feeding. N Engl J Med. 2019;380(14):1296-7. Go to original source...
    34. Rowland Yeo K, Gerhart J, Sawant-Basak A, et al. Clinical lactation studies. Acting on key recommendations over the last decade. NPJ Womens Health. 2025;3(1):19. Go to original source...
    35. VigiBase. [Internet]. Sweden: Uppsala Monitoring Centre; c2025. [cit. 3.2. 2025]. Available from: https://who-umc.org/vigibase.
    36. EudraVigilance: European database of suspected adverse durg reaction reports. [Internet]. European Union: European Medicine Agency; c2025. [cit. 3. 2. 2025]. Available from: https://www.adrreports.eu.
    37. Le CRAT. [Internet]. Paris, France: Le Centre de Référence sur les Agents tératogènes; c2025. [cit. 7. 2. 2025]. Available from: https://www.lecrat.fr/.
    38. Embryotox. [Internet]. Berlin, Germany: Charité - Universitätsmedizin Berlin; c2025. [cit. 7. 2. 2025]. Available from: https://www.embryotox.de/
    39. Teratology Information Services of Lareb. [Internet]. Netherlands Pharmacovigilance Centre Lareb; c2025. [cit. 31. 1. 2025]. Available from: https://www.lareb.nl/en/pages/teratology-information-services-tis/
    40. Trygg Mammamedisin. [Internet]. Norway: RELIS; c2025. [cit. 28. 6. 2022]. Available from: https://tryggmammamedisin.no/.
    41. About OTIS. [Internet]. USA: Organization of Teratology Information Specialists; c2025. [cit. 15. 1. 2025]. Available from: https://mothertobaby.org/about-otis.
    42. MotherToBaby. [Internet]. USA: Organization of Teratology Information Specialists; c2025. [cit. 6. 6. 2025]. Available from: https://mothertobaby.org/.
    43. Lékové informační centrum FAF UK a FN HK. [Internet]. Hradec Králové, ČR: Univerzity Karlova, Farmaceutická fakulta v Hradci Králové; c2025. [cit. 16. 6. 2025]. Available from: https://www.faf.cuni.cz/LIC/.
    44. SPS - Specialist Pharmacy Service. [Internet]. UK: Specialist Pharmacy Service; c2025. [cit. 3. 6. 2025]. Available from: https://www.sps.nhs.uk/
    45. Medicines in Breastfeeding clinical enquiries. [Internet]. UK: UKMI Medicines Information; c2025. [cit. 16. 6. 2025]. Available from: https://www.ukmi.nhs.uk/Contacts?ContentID=7a361825-0ef4-4146-9725-26ab04fe7a56
    46. Infant Risk Center. [Internet]. USA: Texas Tech University Health Sciences Center. [cit. 16. 6. 2025]. Available from: https://www.infantrisk.com.
    47. Oddelenie klinickej farmakológie. [Internet]. Bratislava, SR: Univerzitná nemocnica Ružinov; c2025. [cit. 30. 4. 2025]. Available from: https://www.unb.sk/oddelenie-klinickej-farmakologie/.
    48. Julsgaard M, Nørgaard M, Hvas CL, et al. Self-reported adherence to medical treatment, breastfeeding behaviour, and disease activity during the postpartum period in women with Crohn's disease. Scand J Gastroenterol. 2014;49(8):958-66. Go to original source...
    49. Berwick MAP, Heuberger AJ, Martin JV, et al. Drugs in Lactation. Semin Perinatol. 2025 Jun;49(4):152077. Go to original source...

    Return to the content


    Czech and Slovak Pharmacy

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.